Unorthodox Ventures
Overview
Unorthodox Ventures is an American-based institutional investor focused on partnering with innovative, driven founders. The firm distinguishes itself by adopting a hands-on, operator-centric approach to investing, focusing on early-stage companies that develop innovative solutions to real-world problems. Unorthodox Ventures emphasizes long-term success over short-term gains, partnering with founders who demonstrate both disruption and discipline. They invest in medical technology (medtech) and construction technology (contech), particularly targeting companies in the cardiology and gastrointestinal sectors, as well as those developing software to enhance job-site productivity.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TradingView | May 2026 | Pre Seed | Co-investor |
| Akura Medical | Dec 2025 | Series C | Co-investor |
| Supira Medical | Mar 2025 | Series E | Co-investor |
| Laplace Interventional | Mar 2025 | Series C | Co-investor |
| Exero Medical | Feb 2025 | Seed | Co-investor |
Key People
Adam Kahn
Principal
Anderson Smith
Principal
Brian Smith
Principal
Cuinn Alexander
Principal
Daniel Allen
Principal
Gavin Holiday
Principal
Lewis Kasindi Kilongo
Principal
Tristan Smith
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.